TL;DR: Sensible Biotechnologies is a Y Combinator Summer 2021 startup Unlocking the next generation of mRNA medicines, currently active with a team of 24.
Unlocking the next generation of mRNA medicines
Last verified:
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Built by LemStudio
Yes. Sensible Biotechnologies was funded by Y Combinator in the Summer 2021 batch. Unlocking the next generation of mRNA medicines
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effect…
Sensible Biotechnologies was part of Y Combinator's Summer 2021 batch.
Sensible Biotechnologies has a team of 24 people according to Y Combinator's directory.
Sensible Biotechnologies is currently listed as Active with a team of 24 in Y Combinator's directory.
Loading interactive view…